Treatment of resistant pain in hypertrophic pulmonary osteoarthropathy with subcutaneous octreotide

被引：23
作者：
Johnson, SA
Spiller, PA
Faull, CM
机构：
[1] St. Mary's Hospice, Birmingham B29 7DA, Raddlebarn Road, Selly Park
来源：
THORAX | 1997年 / 52卷 / 03期
关键词：
hypertrophic pulmonary osteoarthropathy; octreotide;
D O I：
10.1136/thx.52.3.298
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
Pain in hypertrophic pulmonary osteoarthropathy (HPOA) due to periostitis and arthropathy can be a particularly disabling symptom, and resistant to a wide variety of treatments. The effectiveness of subcutaneous octreotide in relieving this pain in a patient with HPOA is reported.
引用
收藏
页码：298 / 299
页数：2
相关论文
共 50 条
  • [31] Clinical Course of Hypertrophic Pulmonary Osteoarthropathy in a Patient Receiving Immune Checkpoint Inhibitor Therapy
    Johns, Andrew C.
    Sorenson, Chad
    Rogers, Alan
    Agne, Julia L.
    D'Souza, Desmond M.
    Das, Jishu K.
    Issa, Majd
    Perna, Gina
    Williams, Terence M.
    Meara, Alexa
    Kitchin, Trevor
    Haglund, Karl E.
    Owen, Dwight H.
    [J]. CLINICAL LUNG CANCER, 2020, 21 (04) : E243 - E245
  • [32] A case of pulmonary adenocarcinoma associated with hypertrophic osteoarthropathy due to vascular endothelial growth factor
    Abe, Y
    Kurita, S
    Ohkubo, Y
    Usui, H
    Hashizume, T
    Nakamura, M
    Ueyama, Y
    Fujino, T
    [J]. ANTICANCER RESEARCH, 2002, 22 (6B) : 3485 - 3488
  • [33] Treatment of post-traumatic chyluria with subcutaneous octreotide administration
    Giordano, M
    Cirillo, D
    Baron, I
    Sorrentino, F
    Tomasino, G
    Cicchella, T
    DeBellis, L
    Giordano, C
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1996, 11 (02) : 365 - 367
  • [34] Continuous subcutaneous octreotide in gastrointestinal cancer patients:: Pain control and β-endorphin levels
    Befon, S
    Mystakidou, K
    Lyra, M
    Tubanakis, N
    Vlahos, L
    [J]. ANTICANCER RESEARCH, 2000, 20 (5C) : 4039 - 4046
  • [35] Unusual association of two paraneoplastic syndromes in lung adenocarcinoma: Acquired ichtyosis and hypertrophic pulmonary osteoarthropathy
    Bacha, S.
    Habibech, S.
    Attia, M.
    Chabbou, A.
    [J]. REVUE DE PNEUMOLOGIE CLINIQUE, 2017, 73 (04) : 213 - 215
  • [36] Atypical Presentation of Hypertrophic Pulmonary Osteoarthropathy on Tc-99m MDP Bone Scintigraphy
    Narla, Vinod V.
    Rajagopalan, Malolan S.
    Kanderi, Tanuja
    Muthukrishnan, Ashok
    [J]. CLINICAL NUCLEAR MEDICINE, 2008, 33 (10) : 702 - 704
  • [37] Rapid resolution of hypertrophic pulmonary osteoarthropathy after resection of a lung mass caused by xanthogranulomatous inflammation
    Hung, GU
    Kao, CH
    Lin, WY
    Wang, SJ
    [J]. CLINICAL NUCLEAR MEDICINE, 2000, 25 (12) : 1029 - 1030
  • [38] SUBCUTANEOUS OCTREOTIDE VERSUS ORAL LOPERAMIDE IN THE TREATMENT OF DIARRHEA FOLLOWING CHEMOTHERAPY
    GEBBIA, V
    CARRECA, I
    TESTA, A
    VALENZA, R
    CURTO, G
    CANNATA, G
    BORSELLINO, N
    LATTERI, MA
    CIPOLLA, C
    FLORENA, M
    GEBBIA, N
    [J]. ANTI-CANCER DRUGS, 1993, 4 (04) : 443 - 445
  • [39] Octreotide treatment in patients with necrotizing pancreatitis and pulmonary failure
    Fiedler, F
    Jauernig, G
    Keim, V
    Richter, A
    Bender, HJ
    [J]. INTENSIVE CARE MEDICINE, 1996, 22 (09) : 909 - 915
  • [40] A COMPARISON OF OCTREOTIDE DELIVERED BY CONTINUOUS SUBCUTANEOUS INFUSION WITH INTERMITTENT INJECTION IN THE TREATMENT OF ACROMEGALY
    JAMES, RA
    WHITE, MC
    CHATTERJEE, S
    MARCIAJ, H
    KENDALLTAYLOR, P
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1992, 22 (08) : 554 - 561
12345